相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hyaluronic acid-coated pH sensitive poly (β-amino ester) nanoparticles for co-delivery of embelin and TRAIL plasmid for triple negative breast cancer treatment
Yingqi Xu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Glutathione peroxidase-1 regulates adhesion and metastasis of triple-negative breast cancer cells via FAK signaling
Eunkyung Lee et al.
REDOX BIOLOGY (2020)
Non-SMC Condensin I Complex Subunit D2 Is a Prognostic Factor in Triple-Negative Breast Cancer for the Ability to Promote Cell Cycle and Enhance Invasion
Yajing Zhang et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
FDA Approval Summary: Atezolizumab Plus Paclitaxel Protein-bound for the Treatment of Patients with Advanced or Metastatic TNBC Whose Tumors Express PD-L1
Preeti Narayan et al.
CLINICAL CANCER RESEARCH (2020)
RSK2: a promising therapeutic target for the treatment of triple-negative breast cancer
My-my Huynh et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis
Liuwan Zhao et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Molecularly Engineering Triptolide with Aptamers for High Specificity and Cytotoxicity for Triple-Negative Breast Cancer
Jiaxuan He et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Decreased nonspecific adhesivity, receptor-targeted therapeutic nanoparticles for primary and metastatic breast cancer
Jimena G. Dancy et al.
SCIENCE ADVANCES (2020)
Polarization of tumor-associated macrophage phenotype via porous hollow iron nanoparticles for tumor immunotherapy in vivo
Ke Li et al.
NANOSCALE (2020)
CD44 targeted redox-triggered self-assembly with magnetic enhanced EPR effects for effective amplification of gambogic acid to treat triple-negative breast cancer
Mangmang Sang et al.
BIOMATERIALS SCIENCE (2020)
Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women
Tess O'Meara et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia
Wijden Mahfoudh et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite
Wei-Siang Liao et al.
ACTA BIOMATERIALIA (2019)
The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer
Ikbale El Ayachi et al.
CANCER RESEARCH (2019)
The application of aptamer 5TR1 in triple negative breast cancer target therapy
Shayang Luo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Light-Activated Core-Shell Nanoparticles for Spatiotemporally Specific Treatment of Metastatic Triple-Negative Breast Cancer
Qingshuo Meng et al.
ACS NANO (2018)
Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis
Y. Bareche et al.
ANNALS OF ONCOLOGY (2018)
Oxygen-boosted immunogenic photodynamic therapy with gold nanocages@manganese dioxide to inhibit tumor growth and metastases
Ruijing Liang et al.
BIOMATERIALS (2018)
Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
Nithya Krishnamurthy et al.
CANCER TREATMENT REVIEWS (2018)
Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model
Walhan Alshaer et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Nanocomposites: suitable alternatives as antimicrobial agents
Rupy Kaur Matharu et al.
NANOTECHNOLOGY (2018)
Molecular Subtypes and Local-Regional Control of Breast Cancer
Simona Maria Fragomeni et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2018)
A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer
Zhixian Liu et al.
TRANSLATIONAL ONCOLOGY (2018)
The new TNM-based staging of breast cancer
Gabor Cserni et al.
VIRCHOWS ARCHIV (2018)
Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations
Jaison Jeevanandam et al.
BEILSTEIN JOURNAL OF NANOTECHNOLOGY (2018)
Artificial intelligence, machine learning and the evolution of healthcare A BRIGHT FUTURE OR CAUSE FOR CONCERN?
L. D. Jones et al.
BONE & JOINT RESEARCH (2018)
ZD2-Engineered Gold Nanostar@Metal-Organic Framework Nanoprobes for T1-Weighted Magnetic Resonance Imaging and Photothermal Therapy Specifically Toward Triple-Negative Breast Cancer
Luyun Zhang et al.
ADVANCED HEALTHCARE MATERIALS (2018)
Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity
Lais Salomao Arias et al.
ANTIBIOTICS-BASEL (2018)
Incidence and Mortality and Epidemiology of Breast Cancer in the World
Mahshid Ghoncheh et al.
Asian Pacific Journal of Cancer Prevention (2017)
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer
Gabriele Corda et al.
JOURNAL OF PATHOLOGY (2017)
Triple-negative breast cancer: is there a treatment on the horizon?
Hui Yao et al.
ONCOTARGET (2017)
Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer
Jorgen Elgqvist
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
MicroRNAs in the prognosis of triple-negative breast cancer A systematic review and meta-analysis
Lingshuang Lu et al.
MEDICINE (2017)
Integrated analysis of the potential roles of miRNA-mRNA networks in triple negative breast cancer
Huiru Zhu et al.
MOLECULAR MEDICINE REPORTS (2017)
Efficacy of adjuvant chemotherapy with carboplatin for early triple negative breast cancer: a single center experience
Marcus Vetter et al.
ONCOTARGET (2017)
Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer
Guilhem Bousquet et al.
ONCOTARGET (2017)
Artificial intelligence in healthcare: past, present and future
Fei Jiang et al.
STROKE AND VASCULAR NEUROLOGY (2017)
Rational combination of immunotherapy for triple negative breast cancer treatment
Chia-Wei Li et al.
CHINESE CLINICAL ONCOLOGY (2017)
Artificial intelligence for breast cancer screening: Opportunity or hype?
Nehmat Houssami et al.
BREAST (2017)
Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer
Terri P. McVeigh et al.
BREAST CANCER-TARGETS AND THERAPY (2017)
Diverse Applications of Nanomedicine
Beatriz Pelaz et al.
ACS NANO (2017)
The paradoxical functions of EGFR during breast cancer progression
Remah Ali et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
Quantum dot-based in situ simultaneous molecular imaging and quantitative analysis of EGFR and collagen IV and identification of their prognostic value in triple-negative breast cancer
Hong-Mei Zheng et al.
TUMOR BIOLOGY (2016)
Using Gold Nanoparticles To Disrupt the Tumor Microenvironment: An Emerging Therapeutic Strategy
Jilian R. Melamed et al.
ACS NANO (2016)
Detection and isolation of circulating exosomes and microvesicles for cancer monitoring and diagnostics using micro-/nano-based devices
Jina Ko et al.
ANALYST (2016)
Tailored-CuO-nanowire decorated with folic acid mediated coupling of the mitochondrial-ROS generation and miR425-PTEN axis in furnishing potent anti-cancer activity in human triple negative breast carcinoma cells
Manisha Ahir et al.
BIOMATERIALS (2016)
Inhibition of Sonic Hedgehog Signaling Pathway by Thiazole Antibiotic Thiostrepton Attenuates the CD44+/CD24-Stem-Like Population and Sphere-Forming Capacity in Triple-Negative Breast Cancer
Na Yang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Hyperthermia using nanoparticles - Promises and pitfalls
Punit Kaur et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2016)
Molecular Classification of Triple-Negative Breast Cancer
Sung Gwe Ahn et al.
JOURNAL OF BREAST CANCER (2016)
Evaluation of treatment outcomes of triple-negative breast cancer
Ahmet Cinkaya et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2016)
Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials
Anne Lynn S. Chang et al.
ORPHANET JOURNAL OF RARE DISEASES (2016)
Notch signaling: its roles and therapeutic potential in hematological malignancies
Yisu Gu et al.
ONCOTARGET (2016)
Computer-Aided Diagnosis with Deep Learning Architecture: Applications to Breast Lesions in US Images and Pulmonary Nodules in CT Scans
Jie-Zhi Cheng et al.
SCIENTIFIC REPORTS (2016)
The hedgehog pathway in triple-negative breast cancer
Joyce G. Habib et al.
CANCER MEDICINE (2016)
Multiformat T-Cell-Engaging Bispecific Antibodies Targeting Human Breast Cancers
Yu Cao et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Quantum dots-based tissue and in vivo imaging in breast cancer researches: current status and future perspectives
Lin-Wei Wang et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Role of Hyperthermia in Breast Cancer Locoregional Recurrence: A Review
Sergio Maluta et al.
BREAST CARE (2015)
Therapeutic targets of triple-negative breast cancer: a review
Vinayak S. Jamdade et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration
Nianhang Chen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Notch signaling: An emerging therapeutic target for cancer treatment
Xun Yuan et al.
CANCER LETTERS (2015)
miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer
Andrea Mathe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
William M. Sikov et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Doxorubicin-Hyaluronan Conjugated Super-Paramagnetic Iron Oxide Nanoparticles (DOX-HA-SPION) Enhanced Cytoplasmic Uptake of Doxorubicin and Modulated Apoptosis, IL-6 Release and NF-kappaB Activity in Human MDA-MB-231 Breast Cancer Cells
Dinesh Vyas et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2015)
Anti-PD-L1 for metastatic triple-negative breast cancer
Josefine Gibson
LANCET ONCOLOGY (2015)
Near infrared light-actuated gold nanorods with cisplatin-polypeptide wrapping for targeted therapy of triple negative breast cancer
Bing Feng et al.
NANOSCALE (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances
Jasmine M. Miller-Kleinhenz et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2015)
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
Katarzyna Tomczak et al.
Wspolczesna Onkologia-Contemporary Oncology (2015)
Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6
Yu-Chun Hsiao et al.
ONCOTARGET (2015)
Analysis of the In Vivo and In Vitro Effects of Photodynamic Therapy on Breast Cancer by Using a Sensitizer, Sinoporphyrin Sodium
Xiaobing Wang et al.
THERANOSTICS (2015)
Magnetic Nanoparticles in Cancer Theranostics
Oliviero L. Gobbo et al.
THERANOSTICS (2015)
Thermosensitive Liposome Formulated Indocyanine Green for Near-Infrared Triggered Photodynamic Therapy: In Vivo Evaluation for Triple-Negative Breast Cancer
Colby S. Shemesh et al.
PHARMACEUTICAL RESEARCH (2015)
PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer
Hallie Wimberly et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response
Pascal Jezequel et al.
BREAST CANCER RESEARCH (2015)
Au Nanomatryoshkas as Efficient Near-Infrared Photothermal Transducers for Cancer Treatment: Benchmarking against Nanoshells
Ciceron Ayala-Orozco et al.
ACS NANO (2014)
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
Nicolas Bertrand et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact
J. M. Nabholtz et al.
ANNALS OF ONCOLOGY (2014)
Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients
T. Byrski et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Subtype classification for prediction of prognosis of breast cancer from a biomarker panel: correlations and indications
Chuang Chen et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Quantum dot-based immunofluorescent imaging of Ki67 and identification of prognostic value in HER2-positive (non-luminal) breast
Jin-Zhong Sun et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Nanopharmaceuticals (part I): products on the market
Volkmar Weissig et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Sub-100 nm gold nanomatryoshkas improve photo-thermal therapy efficacy in large and highly aggressive triple negative breast tumors
Ciceron Ayala-Orozco et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Inhibiting Metastatic Breast Cancer Cell Migration via the Synergy of Targeted, pH-triggered siRNA Delivery and Chemokine Axis Blockade
Peng Guo et al.
MOLECULAR PHARMACEUTICS (2014)
Nanodiamond-Mitoxantrone Complexes Enhance Drug Retention in Chemoresistant Breast Cancer Cells
Tan-Boon Toh et al.
MOLECULAR PHARMACEUTICS (2014)
Colocalized Delivery of Rapamycin and Paclitaxel to Tumors Enhances Synergistic Targeting of the PI3K/Akt/mTOR Pathway
Elvin Blanco et al.
MOLECULAR THERAPY (2014)
PI3K and cancer: lessons, challenges and opportunities
David A. Fruman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
ICAM-1 as a molecular target for triple negative breast cancer
Peng Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Cannabinoids as therapeutic agents in cancer: current status and future implications
Bandana Chakravarti et al.
ONCOTARGET (2014)
Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review)
Mei Hong Zhang et al.
BIOMEDICAL REPORTS (2014)
Liposomal drug delivery systems: From concept to clinical applications
Theresa M. Allen et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44)
B. Gerber et al.
ANNALS OF ONCOLOGY (2013)
Wnt signaling in triple negative breast cancer is associated with metastasis
Nandini Dey et al.
BMC CANCER (2013)
Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer
Rachel M. Layman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
Hiroko Masuda et al.
CLINICAL CANCER RESEARCH (2013)
FRET Enhanced Fluorescent Nanodiamonds
Rafal Fudala et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2013)
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
Neil E. Bhola et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study
Miguel Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Randomized Phase II Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer
Jose Baselga et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Biodistribution and pharmacokinetics of uniform magnetite nanoparticles chemically modified with polyethylene glycol
A. Ruiz et al.
NANOSCALE (2013)
Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer
Luciano Cascione et al.
PLOS ONE (2013)
Notch inhibitors for cancer treatment
Ingrid Espinoza et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment
Koichiro Hayashi et al.
THERANOSTICS (2013)
Combining Notch inhibition with current therapies for breast cancer treatment
Keith Brennan et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2013)
Mechanisms of chemoresistance in cancer stem cells
Lissa Nurrul Abdullah et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2013)
The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy
Mun Hui et al.
BREAST CANCER RESEARCH (2013)
Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency
Rachel L. Atkinson et al.
BREAST CANCER RESEARCH (2013)
Aptamers: Problems, Solutions and Prospects
A. V. Lakhin et al.
ACTA NATURAE (2013)
Single-stranded DNA (ssDNA) production in DNA aptamer generation
Citartan Marimuthu et al.
ANALYST (2012)
Imaging of triple-negative breast cancer
B. E. Dogan et al.
ANNALS OF ONCOLOGY (2012)
The diverse roles and clinical relevance of PARPs in DNA damage repair: Current state of the art
Mike De Vos et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoembolisation for hepatocellular carcinoma <5 cm: comparison with transarterial chemoembolisation monotherapy-preliminary observations
J. Kim et al.
BRITISH JOURNAL OF RADIOLOGY (2012)
mTOR inhibitors in cancer therapy
Yekaterina Y. Zaytseva et al.
CANCER LETTERS (2012)
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Junko Murai et al.
CANCER RESEARCH (2012)
Biological applications of magnetic nanoparticles
Miriam Colombo et al.
CHEMICAL SOCIETY REVIEWS (2012)
Targeting the Hedgehog signaling pathway for cancer therapy
Yiwei Li et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Poly(Adenosine Diphosphate-Ribose) Polymerase Inhibitors in Cancer Treatment
Sook Ryun Park et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2012)
The Effect of Sodium Dodecyl Sulfate (SDS) and Cetyltrimethylammonium Bromide (CTAB) on the Properties of ZnO Synthesized by Hydrothermal Method
Donya Ramimoghadam et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
Lisa A. Carey et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Radiofrequency Ablation in the Management of Unresectable Intrahepatic Cholangiocarcinoma
Ying Fu et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2012)
A Monoclonal Antibody against Human Notch1 Ligand-Binding Domain Depletes Subpopulation of Putative Breast Cancer Stem-like Cells
Ankur Sharma et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Dvl2-Dependent Activation of Daam1 and RhoA Regulates Wnt5a-Induced Breast Cancer Cell Migration
Yichao Zhu et al.
PLOS ONE (2012)
Leukocyte composition of human breast cancer
Brian Ruffell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
Austin Gurney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
PARP-1 Activation- Bringing the Pieces Together
Jean-Philippe Gagne et al.
SCIENCE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Locoregional Recurrence in Patients With Triple-Negative Breast Cancer Preliminary Results of a Single Institution Study
Anthony E. Dragun et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2011)
Purification and Magnetic Interrogation of Hybrid Au-Fe3O4 and FePt-Fe3O4 Nanoparticles
Jacob S. Beveridge et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S. Aebi et al.
ANNALS OF ONCOLOGY (2011)
Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation
J. E. Panoff et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Photodynamic Therapy of Cancer: An Update
Patrizia Agostinis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles
Leif W. Ellisen
CANCER CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey
S. Verma et al.
Current Oncology (2011)
The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology
Suzanne A. Eccles
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2011)
Gold nanorods as new nanochromophores for photothermal therapies
Fulvio Ratto et al.
JOURNAL OF BIOPHOTONICS (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Increased Risk of Locoregional Recurrence for Women With T1-2N0 Triple-Negative Breast Cancer Treated With Modified Radical Mastectomy Without Adjuvant Radiation Therapy Compared With Breast-Conserving Therapy
Bassam S. Abdulkarim et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation
Felipe C. Geyer et al.
MODERN PATHOLOGY (2011)
The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings
Thomas Helleday
MOLECULAR ONCOLOGY (2011)
Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer
Lara Milane et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Inhibiting metastasis of breast cancer cells in vitro using gold nanorod-siRNA delivery system
Weiqi Zhang et al.
NANOSCALE (2011)
Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate
Cecilia E. Strom et al.
NUCLEIC ACIDS RESEARCH (2011)
Methods for L-ribooligonucleotide sequence determination using LCMS
John J. Turner et al.
NUCLEIC ACIDS RESEARCH (2011)
Nanodiamond Therapeutic Delivery Agents Mediate Enhanced Chemoresistant Tumor Treatment
Edward K. Chow et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
A New Era for Cancer Treatment: Gold-Nanoparticle-Mediated Thermal Therapies
Laura C. Kennedy et al.
SMALL (2011)
Targeting EGFR in Triple Negative Breast Cancer
Naoto T. Ueno et al.
JOURNAL OF CANCER (2011)
Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells
Craig A. Cooney et al.
BREAST CANCER RESEARCH (2011)
Luminescent Carbon Nanodots: Emergent Nanolights
Sheila N. Baker et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermia
Pol-Edern Le Renard et al.
BIOMATERIALS (2010)
Chemotherapy and signaling How can targeted therapies supercharge cytotoxic agents?
Tetyana Bagnyukova et al.
CANCER BIOLOGY & THERAPY (2010)
Triple-Negative Breast Cancer Role of Specific Chemotherapy Agents
Steven J. Isakoff
CANCER JOURNAL (2010)
Triple-Negative Breast Cancer Epidemiology and Management Options
Shaheenah Dawood
DRUGS (2010)
Review: Nanocomposites in Food Packaging
Amit Arora et al.
JOURNAL OF FOOD SCIENCE (2010)
CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer
Xinhui Wang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Single-Wall Carbon Nanotubes Assisted Photothermal Cancer Therapy: Animal Study With a Murine Model of Squamous Cell Carcinoma
Naiyan Huang et al.
LASERS IN SURGERY AND MEDICINE (2010)
Conscripts of the infinite armada: systemic cancer therapy using nanomaterials
David A. Scheinberg et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Inorganic Nanoparticles as Protein Mimics
Nicholas A. Kotov
SCIENCE (2010)
Preoperative weekly cisplatin-epirubicin-paclitaxel with G-CSF support in triple-negative large operable breast cancer
G. Frasci et al.
ANNALS OF ONCOLOGY (2009)
Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer
B. Corkery et al.
ANNALS OF ONCOLOGY (2009)
Triple-negative breast cancer-current status and future directions
O. Gluz et al.
ANNALS OF ONCOLOGY (2009)
Locoregional Recurrence of Triple-negative Breast Cancer After Breast-conserving Surgery and Radiation
Gary M. Freedman et al.
CANCER (2009)
Multiparametric Monitoring of Tumor Response to Chemotherapy by Noninvasive Imaging
Zdravka Medarova et al.
CANCER RESEARCH (2009)
The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis
Rui Benedito et al.
CELL (2009)
Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design
Farrah Kassam et al.
CLINICAL BREAST CANCER (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Potential Chemotherapy Side Effects: What Do Oncologists Tell Parents?
Lisa Ysela Ramirez et al.
PEDIATRIC BLOOD & CANCER (2009)
Hedgehog signalling in vascular development
Takashi Nagase et al.
ANGIOGENESIS (2008)
Multi-functional nanocarriers to overcome tumor drug resistance
Lara S. Jabr-Milane et al.
CANCER TREATMENT REVIEWS (2008)
'Triple negative' breast cancer: a new area for phase III breast cancer clinical trials
L. S. Kilburn
CLINICAL ONCOLOGY (2008)
Interaction of calf thymus DNA with a cationic tetrandrine derivative at the air-water interface
Amparo Wong-Molina et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2008)
Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
Priya Rastogi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
HER2 status and efficacy of adjuvant anthracyclines in early breast cancer:: A pooled analysis of randomized trials
Alessandra Gennari et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging
Lily Yang et al.
Journal of Biomedical Nanotechnology (2008)
Methods for selection of aptamers to protein targets
A. V. Kulbachinskiy
BIOCHEMISTRY-MOSCOW (2007)
Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth
Christine F. O'Neill et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
The phosphoinositide 3-kinase pathway in human cancer: Genetic alterations and therapeutic implications
Alexandre Arcaro et al.
CURRENT GENOMICS (2007)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer
Sven Rottenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy
Andre M. Gobin et al.
NANO LETTERS (2007)
Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia
Steven M. Chan et al.
BLOOD (2007)
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
Lisa A. Carey et al.
CLINICAL CANCER RESEARCH (2007)
Micellar nanocarriers: Pharmaceutical perspectives
V. P. Torchilin
PHARMACEUTICAL RESEARCH (2007)
Signalling pathways implicated in early mammary gland morphogenesis and breast cancer
Beatrice Howard et al.
PLOS GENETICS (2006)
CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to γ-secretase inhibitors
T. Palomero et al.
LEUKEMIA (2006)
DNA aptamers that bind to MUC1 tumour marker: Design and characterization of MUC1-binding single-stranded DNA aptamers
C. S. M. Ferreira et al.
TUMOR BIOLOGY (2006)
Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade
AV Maker et al.
JOURNAL OF IMMUNOLOGY (2005)
Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: A microscopic overview
R Shukla et al.
LANGMUIR (2005)
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
R Rouzier et al.
CLINICAL CANCER RESEARCH (2005)
Quantum dots for live cells, in vivo imaging, and diagnostics
X Michalet et al.
SCIENCE (2005)
Molecular mechanisms of drug resistance
DB Longley et al.
JOURNAL OF PATHOLOGY (2005)
Phase II study of neoadjuvant paclitaxel and cisplatin for operable and locally advanced breast cancer: analysis of 126 patients
AA Ezzat et al.
BRITISH JOURNAL OF CANCER (2004)
Evidence for the Notch signaling pathway on the role of estrogen in angiogenesis
R Soares et al.
MOLECULAR ENDOCRINOLOGY (2004)
Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer
M Kubo et al.
CANCER RESEARCH (2004)
Mutations in the Desert hedgehog (DHH) gene in patients with 46,XY complete pure gonadal dysgenesis
P Canto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia
AP Weng et al.
SCIENCE (2004)
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
C Sotiriou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Nanotechnology: convergence with modern biology and medicine
MC Roco
CURRENT OPINION IN BIOTECHNOLOGY (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer
IC Henderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells
S Weijzen et al.
NATURE MEDICINE (2002)
Carbon nanotubes - the route toward applications
RH Baughman et al.
SCIENCE (2002)
Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues
MJ Thun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins
JM Pleschke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
